MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
Nabanita Mukherjee(University of Colorado Anschutz Medical Campus), Yiqun G. Shellman(University of Colorado Anschutz Medical Campus)
Cited by 71
Related Papers
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
|Cell Death and Disease|2018|27
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine
|Pharmaceuticals|2021|5